Additional information
| Active substance | Rivaroxaban |
|---|---|
| Acne | No |
| Water Retention | No |
| HBR | No |
| Hepatotoxicity | No |
| Aromatization | No |
| Lab Test | Anti-factor Xa activity can indirectly measure its effect but is not routinely monitored |
| Also known as | BAY 59-7939 |
| WAREHOUSE | International Warehouse 2 |
| Blood pressure | No significant effect on blood pressure |
| Trade name | Xarelto |
| Storage conditions | Store at 15В°C to 30В°C (59В°F to 86В°F) in a dry place |
| Chemical name | Rivaroxaban |
| Formula | C19H18ClN3O5S |
| Substance class | Anticoagulant |
| Main action | Inhibits thrombin formation by directly targeting Factor Xa |
| Half-life | 5 to 9 hours in healthy individuals, up to 11 to 13 hours in the elderly |
| Dosage (medical) | 10 mg, 15 mg, or 20 mg tablets once daily, depending on the condition being treated |
| Dosage (sports) | N/A |
| Effects | Reduces the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation, treats deep vein thrombosis and pulmonary embolism, prevents blood clots in certain patients |
| Side effects | Bleeding, anemia, liver enzyme changes, dizziness, headache, rash |
| Use in sports | Not typically used in sports |
| Manufacturer | Bayer |
LACIPIL 4 mg Glaxosmithkline
Clen 40 SINGANI PHARMA
Norvacs 5 mg Pfizer
Balkan Pharma Danabol 50 mg 60 Tabletten
Thyromazol 5 mg Abdi Ibragim
Bvs Labs Dianabol 10mg 100 Tabletten
Spiriva HandiHaler 18mg Boehringer Ingelheim
Prograf 5mg Astellas Pharma
Seretide Disckus (Advair) 250 mcg Glaxosmithkline
Champix Starter Pack Pfizer
Rovamycine 3.000.000 iu Eczacibasi
Prograf 1mg Astellas Pharma
Sibutramine Atlas Pharma
Januvia 100mg Merckgroup
Norvacs 10 mg Pfizer
Fostimon (Merional) 75 (HMG) IBSA 

Reviews
There are no reviews yet.